AstraZeneca beat expectations for third quarter earnings on Thursday with strong sales of its blockbuster cancer and cardiovascular drugs, but disappointed some investors by not raising its full-year ...

AstraZeneca reported its largest quarterly revenue ever, as soaring sales of cancer drugs helped the drugmaker beat ...

The pharmaceutical company posted a 14% on-year increase in third-quarter core earnings per share, while revenue rose to ...

AstraZeneca (AZN.L) has informed the European Commission that it will initially not be able to deliver the agreed volumes of ...

COVID-19 vaccine would continue despite many European nations pausing vaccination to investigate serious side effects ...

AstraZeneca has ended work on one of its potential drugs for fatty liver disease after viewing disappointing data from a ...

AstraZeneca ( AZN) posted stronger-than-expected Q3 results, fueled by continued strength in its oncology portfolio. The U.K.

British pharmaceutical giant AstraZeneca announced surging quarterly profit Thursday on strong sales of cancer drugs and as ...

Across our pipeline we have announced an unprecedented 16 positive Phase III trials this year, with four since our previous results including high-impact readouts for baxdrostat in hypertension and ...

AstraZeneca said work on its new plant north of Charlottesville will begin immediately and be open within five years.

AstraZeneca beat third-quarter earnings expectations on Thursday, helped by strong sales of key cancer, heart and kidney ...